Authors: Gottfried Schlaug, Andrea Norton, Sarah Marchina, Lauryn Zipse, and Catherine Y Wan
Publication: Future Neurology
Publication volume & date: 2010 September; 5(5): 657–665.
Link to full text: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2982746/
Abridged Abstract: …patients with severe nonfluent aphasia are better at singing lyrics than they are at speaking the same words. This observation led to the development of melodic intonation therapy (MIT). However, the efficacy of this therapy has yet to be substantiated in a randomized controlled trial. Furthermore, its underlying neural mechanisms remain unclear. The two unique components of MIT are the intonation of words and simple phrases using a melodic contour that follows the prosody of speech and the rhythmic tapping of the left hand that accompanies the production of each syllable and serves as a catalyst for fluency. Research has shown that both components are capable of engaging fronto–temporal regions in the right hemisphere, thereby making MIT particularly well suited for patients with large left hemisphere lesions who also suffer from nonfluent aphasia…
Next........
No comments:
Post a Comment